A24-Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Clinical Trial to Evaluate Efficacy and Safety of Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD) - Clairvoyant Therapeutics (ClinicalTrials.gov, 2024)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com